Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.
Circulation. 2008 Apr 1;
117(
13):
1649-57. Epub 2008 Mar 17.
PMID:
18347211 [PubMed - indexed for MEDLINE]